{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:30:23Z","timestamp":1784824223496,"version":"3.55.0"},"reference-count":56,"publisher":"Bentham Science Publishers Ltd.","issue":"13","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2019,8,27]]},"DOI":"10.2174\/156802661913190827102426","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T12:13:38Z","timestamp":1566908018000},"page":"1071-1074","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prospects of Utilizing Computational Techniques for the Treatment of Human Diseases"],"prefix":"10.2174","volume":"19","author":[{"given":"Anuraj","family":"Nayarisseri","sequence":"first","affiliation":[{"name":"In silico Research Laboratory Eminent Biosciences Mahalakshmi Nagar, Indore - 452010 Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2174\/1568026619666181210150044","volume":"18","author":"Sinha K.","year":"2018","unstructured":"Sinha K.; Majhi M.; Thakur G.; Patidar K.; Sweta J.; Nayarisseri A.; Singh S.K.; Computer aided drug designing for the identification of high affinity small molecule targeting CD20 for the clinical treatment of Chronic Lymphocytic Leukemia (CLL). Curr Top Med Chem 2018,18(29),2527-2542","journal-title":"Curr Top Med Chem"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.7314\/APJCP.2016.17.4.2291","volume":"17","author":"Patidar K.","year":"2016","unstructured":"Patidar K.; Deshmukh A.; Bandaru S.; Lakkaraju C.; Girdhar A.; Vr G.; Singh S.K.; Virtual screening approaches in identification of bioactive compounds akin to Delphinidin as potential HER2 inhibitors for the treatment of breast cancer. Asian Pac J Cancer Prev 2016,17(4),2291-2295","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","volume":"52","author":"Cheng F.","year":"2012","unstructured":"Cheng F.; Li W.; Zhou Y.; Shen J.; Wu Z.; Liu G.; Tang Y.; admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 2012,52(11),3099-3105","journal-title":"J Chem Inf Model"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2217\/pgs.14.170","volume":"16","author":"Niu N.","year":"2015","unstructured":"Niu N.; Wang L.; \n                        In vitro human cell line models to predict clinical response to anticancer drugs. Pharmacogenomics 2015,16(3),273-285","journal-title":"Pharmacogenomics"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3390\/cancers3011111","volume":"3","author":"Chiodi I.","year":"2011","unstructured":"Chiodi I.; Belgiovine C.; Don\u00e0 F.; Scovassi A.I.; Mondello C.; Drug treatment of cancer cell lines: A way to select for cancer stem cells? Cancers 2011,3(1),1111-1128","journal-title":"Cancers"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.17305\/bjbms.2004.3405","volume":"4","author":"Nikolin B.","year":"2004","unstructured":"Nikolin B.; Imamovi\u0107 B.; Medanhod\u017ei\u0107-Vuk S.; Sober M.; High performance liquid chromatography in pharmaceutical analyses. Bosn J Basic Med Sci 2004,4(2),5-9","journal-title":"Bosn J Basic Med Sci"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1351\/pac200173091429","volume":"73","author":"Heller M.","year":"2001","unstructured":"Heller M.; Kessler H.; NMR spectroscopy in drug design. Pure Appl Chem 2001,73(9),1429-1436","journal-title":"Pure Appl Chem"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12094-006-0048-2","volume":"8","author":"Carnero A.","year":"2006","unstructured":"Carnero A.; High throughput screening in drug discovery. Clin Transl Oncol 2006,8(7),482-490","journal-title":"Clin Transl Oncol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.2174\/1568026618666181115092001","volume":"18","author":"Khandelwal R.","year":"2018","unstructured":"Khandelwal R.; Chauhan A.P.S.; Hussain T.; Hood E.A.; Nayarisseri A.; Structure-based virtual screening for the identification of high affinity small molecule towards STAT3 for the clinical treatment of Osteosarcoma. Curr Top Med Chem 2018,18(29),2511-2526","journal-title":"Curr Top Med Chem"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2174\/1568026617666170821124512","volume":"17","author":"Sharda S.","year":"2017","unstructured":"Sharda S.; Sarmandal P.; Cherukommu S.; Dindhoria K.; Yadav M.; Bandaru S.; Nayarisseri A.; A Virtual screening approach for the identification of high affinity small molecules targeting BCR-ABL1 inhibitors for the treatment of chronic myeloid leukemia. Curr Top Med Chem 2017,17(26),2989-2996","journal-title":"Curr Top Med Chem"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.2174\/1381612822666160513145721","volume":"22","author":"Bandaru S.","year":"2016","unstructured":"Bandaru S.; Alvala M.; Akka J.; Sagurthi S.R.; Nayarisseri A.; Kumar Singh S.; Prasad M.H.; Identification of small molecule as a high affinity \u03b22 agonist promiscuously targeting wild and mutated (Thr164Ile) \u03b2 2 adrenergic receptor in the treatment of bronchial asthma. Curr Pharm Des 2016,22(34),5221-5233","journal-title":"Curr Pharm Des"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1568026615666150112114337","volume":"15","author":"Sinha C.","year":"2015","unstructured":"Sinha C.; Nischal A.; Bandaru S.; Kasera P.; Rajput A.; Nayarisseri A.; Khattri S.; An in silico approach for identification of novel inhibitors as a potential therapeutics targeting HIV-1 viral infectivity factor. Curr Top Med Chem 2015,15(1),65-72","journal-title":"Curr Top Med Chem"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.6026\/97320630010611","volume":"10","author":"Sinha C.","year":"2014","unstructured":"Sinha C.; Nischal A.; Pant K.K.; Bandaru S.; Nayarisseri A.; Khattri S.; Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition. Bioinformation 2014,10(10),611","journal-title":"Bioinformation"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.6026\/97320630010652","volume":"10","author":"Bandaru S.","year":"2014","unstructured":"Bandaru S.; Marri V.K.; Kasera P.; Kovuri P.; Girdhar A.; Mittal D.R.; Ikram S.; GV, R. Nayarisseri, A. Structure based virtual screening of ligands to identify cysteinyl leukotriene receptor 1 antagonist. Bioinformation 2014,10(10),652","journal-title":"Bioinformation"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1568026615666150112113627","volume":"15","author":"Dunna N.R.","year":"2015","unstructured":"Dunna N.R.; Bandaru S.; Raj Akare U.; Rajadhyax S.; Ravi Gutlapalli V.; Yadav M.; Nayarisseri A.; Multiclass comparative virtual screening to identify novel Hsp90 inhibitors: a therapeutic breast cancer drug target. Curr Top Med Chem 2015,15(1),57-64","journal-title":"Curr Top Med Chem"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.7314\/APJCP.2015.16.9.3759","volume":"16","author":"Bandaru S.","year":"2014","unstructured":"Bandaru S.; Ponnala D.; Lakkaraju C.; Kumar C.; Bhukya U.S.; Nayarisseri A.; Identification of high affinity non-peptidic small molecule inhibitors of MDM2-p53 interactions through structure-based virtual screening strategies. Asian Pac J Cancer Prev 2014,16,3759-3765","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.6026\/97320630010737","volume":"10","author":"Akare U.R.","year":"2014","unstructured":"Akare U.R.; Bandaru S.; Shaheen U.; Singh P.K.; Tiwari G.; Singare P.; Nayarisseri A.; Banerjee T.; Molecular docking approaches in identification of high affinity inhibitors of human SMO receptor. Bioinformation 2014,10(12),737-742","journal-title":"Bioinformation"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2174\/15680266113139990115","volume":"13","author":"Bandaru S.","year":"2013","unstructured":"Bandaru S.; Hema Prasad M.; Jyothy A.; Nayarisseri A.; Yadav M.; Binding Modes and Pharmacophoric Features of Muscarinic Antagonism and \u03b22 Agonism (MABA) Conjugates. Curr Top Med Chem 2013,13(14),1650-1655","journal-title":"Curr Top Med Chem"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jopr.2013.02.020","volume":"7","author":"Nayarisseri A.","year":"2013","unstructured":"Nayarisseri A.; Moghni S.M.; Yadav M.; Kharate J.; Sharma P.; Chandok K.H.; Shah K.P.; In silico investigations on HSP90 and its inhibition for the therapeutic prevention of breast cancer. J Pharma Res 2013,7(2),150-156","journal-title":"J Pharma Res"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.6026\/97320630011131","volume":"11","author":"Shaheen U.","year":"2015","unstructured":"Shaheen U.; Akka J.; Hinore J.S.; Girdhar A.; Bandaru S.; Sumithnath T.G.; Nayarisseri A.; Munshi A.; Computer aided identification of sodium channel blockers in the clinical treatment of epilepsy using molecular docking tools. Bioinformation 2015,11(3),131-137","journal-title":"Bioinformation"},{"key":"ref=21","first-page":"791","volume":"6","author":"Vuree S.","year":"2013","unstructured":"Vuree S.; Dunna N.R.; Khan I.A.; Alharbi K.K.; Vishnupriya S.; Soni D.; Shah P.; Chandok H.; Yadav M.; Nayarisseri A.; Pharmacogenomics of drug resistance in Breast Cancer Resistance Protein (BCRP) and its mutated variants. J Pharm Res 2013,6(7),791-798","journal-title":"J Pharm Res"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.7314\/APJCP.2015.16.18.8191","volume":"16","author":"Gudala S.","year":"2015","unstructured":"Gudala S.; Khan U.; Kanungo N.; Bandaru S.; Hussain T.; Parihar M.L.; Mundluru H.P.; Identification and pharmacological analysis of high efficacy small molecule inhibitors of EGF-EGFR interactions in clinical treatment of non-small cell lung carcinoma: A computational approach. Asian Pac J Cancer Prev 2015,16,8191-8196","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.6026\/97320630011378","volume":"11","author":"Babitha P.P.","year":"2015","unstructured":"Babitha P.P.; Sahila M.M.; Bandaru S.; Nayarisseri A.; Sureshkumar S.; Molecular docking and pharmacological investigations of rivastigmine-fluoxetine and coumarin\u2013tacrine hybrids against acetyl choline esterase. Bioinformation 2015,11(8),378-386","journal-title":"Bioinformation"},{"key":"ref=24","first-page":"64","volume":"64","author":"Natchimuthu V.","year":"2016","unstructured":"Natchimuthu V.; Bandaru S.; Nayarisseri A.; Ravi S.; Design, synthesis and computational evaluation of a novel intermediate salt of N-cyclohexyl-N-(cyclohexylcarbamoyl)-4-(trifluoromethyl) benzamide as potential potassium channel blocker in epileptic paroxysmal seizures. Curr Top Med Chem 2016,64,64-73","journal-title":"Curr Top Med Chem"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.6026\/97320630011280","volume":"11","author":"Sahila M.M.","year":"2015","unstructured":"Sahila M.M.; Babitha P.P.; Bandaru S.; Nayarisseri A.; Doss V.A.; Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives. Bioinformation 2015,11(6),280-289","journal-title":"Bioinformation"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2016.07.043","volume":"592","author":"Bandaru S.","year":"2016","unstructured":"Bandaru S.; Tarigopula P.; Akka J.; Marri V.K.; Kattamuri R.K.; Nayarisseri A.; Mangalarapu M.; Vinukonda S.; Mundluru H.P.; Sagurthi S.R.; Association of Beta 2 adrenergic receptor (Thr164Ile) polymorphism with Salbutamol refractoriness in severe asthmatics from Indian population. Gene 2016,592(1),15-22","journal-title":"Gene"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.6026\/97320630012092","volume":"12","author":"Khandekar N.","year":"2016","unstructured":"Khandekar N.; Singh S.; Shukla R.; Tirumalaraju S.; Bandaru S.; Banerjee T.; Nayarisseri A.; Structural basis for the in vitro known acyl-depsipeptide 2 (ADEP2) inhibition to Clp 2 protease from Mycobacterium tuberculosis. Bioinformation 2016,12(3),92-97","journal-title":"Bioinformation"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.6026\/97320630011307","volume":"11","author":"Nasr A.B.","year":"2015","unstructured":"Nasr A.B.; Ponnala D.; Sagurthi S.R.; Kattamuri R.K.; Marri V.K.; Gudala S.; Nayarisseri A.; Molecular Docking studies of FKBP12-mTOR inhibitors using binding predictions. Bioinformation 2015,11(6),307-315","journal-title":"Bioinformation"},{"key":"ref=29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186666","volume":"12","author":"Bandaru S.","year":"2017","unstructured":"Bandaru S.; Alvala M.; Nayarisseri A.; Sharda S.; Goud H.; Mundluru H.P.; Singh S.K.; Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of \u03b22 adrenergic receptor. PLoS One 2017,12(10)","journal-title":"PLoS One"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.6026\/97320630015068","volume":"15","author":"Jain D.","year":"2019","unstructured":"Jain D.; Udhwani T.; Sharma S.; Gandhe A.; Reddy P.B.; Nayarisseri A.; Singh S.K.; Design of novel JAK3 inhibitors towards rheumatoid arthritis using molecular docking analysis. Bioinformation 2019,15(2),68-78","journal-title":"Bioinformation"},{"key":"ref=31","first-page":"21","volume":"2018","author":"Monteiro A.F.M.","year":"2018","unstructured":"Monteiro A.F.M.; Viana J.D.O.; Nayarisseri A.; Zondegoumba E.N.; Junior F.J.B.M.; Scotti M.T.; Scotti L.; Computational studies applied to flavonoids against alzheimer\u2019s and parkinson\u2019s diseases. Oxid Med Cell Longev 2018,2018,21","journal-title":"Oxid Med Cell Longev"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2174\/1568026619666181120121528","volume":"18","author":"Nayarisseri A.","year":"2018","unstructured":"Nayarisseri A.; Hood E.A.; Advancement in microbial cheminformatics. Curr Top Med Chem 2018,18(29),2459-2461","journal-title":"Curr Top Med Chem"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.6026\/97320630015104","volume":"15","author":"Gokhale P.","year":"2019","unstructured":"Gokhale P.; Chauhan A.P.S.; Arora A.; Khandekar N.; Nayarisseri A.; Singh S.K.; FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia. Bioinformation 2019,15(2),104-115","journal-title":"Bioinformation"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.6026\/97320630015121","volume":"15","author":"Shukla P.","year":"2019","unstructured":"Shukla P.; Khandelwal R.; Sharma D.; Dhar A.; Nayarisseri A.; Singh S.K.; Virtual screening of IL-6 inhibitors for idiopathic arthritis. Bioinformation 2019,15(2),121-130","journal-title":"Bioinformation"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.6026\/97320630015139","volume":"15","author":"Udhwani T.","year":"2019","unstructured":"Udhwani T.; Mukherjee S.; Sharma K.; Sweta J.; Khandekar N.; Nayarisseri A.; Singh S.K.; Design of PD-L1 inhibitors for lung cancer. Bioinformation 2019,15(2),139-150","journal-title":"Bioinformation"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.9735\/0975-3087.2.1.5-9","volume":"2","author":"Rao D.M.","year":"2010","unstructured":"Rao D.M.; Nayarisseri A.; Yadav M.; Patel D.; Comparative modeling of methylentetrahydrofolate reductase (MTHFR) enzyme and its mutational assessment: In silico approach. Int J Bioinform Res 2010,2(1),5-9","journal-title":"Int J Bioinform Res"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.7314\/APJCP.2014.15.23.10137","volume":"15","author":"Kelotra S.","year":"2014","unstructured":"Kelotra S.; Jain M.; Kelotra A.; Jain I.; Bandaru S.; Nayarisseri A.; Bidwai A.; An in silico appraisal to identify high affinity anti-apoptotic synthetic tetrapeptide inhibitors targeting the mammalian caspase 3 enzyme. Asian Pac J Cancer Prev 2014,15(23),10137-10142","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.6026\/97320630011517","volume":"11","author":"Gutlapalli V.R.","year":"2015","unstructured":"Gutlapalli V.R.; Sykam A.; Nayarisseri A.; Suneetha S.; Suneetha L.M.; Insights from the predicted epitope similarity between Mycobacterium tuberculosis virulent factors and its human homologs. Bioinformation 2015,11(12),517-524","journal-title":"Bioinformation"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12539-013-0183-8","volume":"5","author":"Nayarisseri A.","year":"2013","unstructured":"Nayarisseri A.; Yadav M.; Wishard R.; Computational evaluation of new homologous down regulators of Translationally Controlled Tumor Protein (TCTP) targeted for tumor reversion. Interdiscip Sci 2013,5(4),274-279","journal-title":"Interdiscip Sci"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7314\/APJCP.2016.17.3.1571","volume":"17","author":"Praseetha S.","year":"2016","unstructured":"Praseetha S.; Bandaru S.; Nayarisseri A.; Sureshkumar S.; Pharmacological analysis of vorinostat analogues as potential anti-tumor agents targeting human histone deacetylases: an epigenetic treatment stratagem for cancers. Asian Pac J Cancer Prev 2016,17(3),1571-1576","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.2174\/1568026619666181129144107","volume":"18","author":"Majhi M.","year":"2018","unstructured":"Majhi M.; Ali M.A.; Limaye A.; Sinha K.; Bairagi P.; Chouksey M.; Shukla R.; Kanwar N.; Hussain T.; Nayarisseri A.; Singh S.K.; An In silico investigation of potential egfr inhibitors for the clinical treatment of colorectal cancer. Curr Top Med Chem 2018,18(27),2355-2366","journal-title":"Curr Top Med Chem"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.2174\/1568026619666181130142237","volume":"18","author":"Sharma K.","year":"2018","unstructured":"Sharma K.; Patidar K.; Ali M.A.; Patil P.; Goud H.; Hussain T.; Nayarisseri A.; Singh S.K.; Structure-based virtual screening for the identification of high affinity compounds as potent vegfr2 inhibitors for the treatment of renal cell carcinoma. Curr Top Med Chem 2018,18(25),2174-2185","journal-title":"Curr Top Med Chem"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2174\/1570159X1508171114113425","volume":"15","author":"Shameer K.","year":"2017","unstructured":"Shameer K.; Nayarisseri A.; Duran F.X.R.; Gonz\u00e1lez-D\u00edaz H.; Improving neuropharmacology using big data, machine learning and computational algorithms. Curr Neuropharmacol 2017,15(8),1058-1061","journal-title":"Curr Neuropharmacol"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.2174\/138161282234161110222751","volume":"22","author":"Basak S.C.","year":"2016","unstructured":"Basak S.C.; Nayarisseri A.; Gonz\u00e1lez-D\u00edaz H.; Bonchev D.; Editorial thematic issue: Chemoinformatics models for pharmaceutical design, part 2. Curr Pharm Des 2016,22(34),5177-5178","journal-title":"Curr Pharm Des"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.2174\/138161282233161109224932","volume":"22","author":"Basak S.C.","year":"2016","unstructured":"Basak S.C.; Nayarisseri A.; Gonz\u00e1lez-D\u00edaz H.; Bonchev D.; Editorial thematic issue: Chemoinformatics models for pharmaceutical design, Part 1. Curr Pharm Des 2016,22(33),5041-5042","journal-title":"Curr Pharm Des"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.6026\/97320630010743","volume":"10","author":"Kelotra A.","year":"2014","unstructured":"Kelotra A.; Gokhale S.M.; Kelotra S.; Mukadam V.; Nagwanshi K.; Bandaru S.; Nayarisseri A.; Bidwai A.; Alkyloxy carbonyl modified hexapeptides as a high affinity compounds for Wnt5A protein in the treatment of psoriasis. Bioinformation 2014,10(12),743-749","journal-title":"Bioinformation"},{"key":"ref=47","first-page":"913","volume":"6","author":"Chandrakar B.","year":"2013","unstructured":"Chandrakar B.; Jain A.; Roy S.; Gutlapalli V.R.; Saraf S.; Suppahia A.; Verma A.; Tiwari A.; Yadav M.; Nayarisseri A.; Molecular modeling of Acetyl-CoA carboxylase (ACC) from Jatropha curcas and virtual screening for identification of inhibitors. J Pharm Res 2013,6(9),913-918","journal-title":"J Pharm Res"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/156802661903190328155731","volume":"19","author":"Nayarisseri A.","year":"2019","unstructured":"Nayarisseri A.; Singh S.K.; Functional inhibition of VEGF and EGFR suppressors in cancer treatment. Curr Top Med Chem 2019,19(3),178-179","journal-title":"Curr Top Med Chem"},{"key":"ref=49","volume":"2018","author":"Monteiro A.F.M.","year":"2018","unstructured":"Monteiro A.F.M.; Viana J.D.O.; Nayarisseri A.; Zondegoumba E.N.; Junior F.J.B.M.; Scotti M.T.; Scotti L.; Computational studies applied to flavonoids against alzheimer\u2019s and parkinson\u2019s diseases. Oxid Med Cell Longev 2018,2018","journal-title":"Oxid Med Cell Longev"},{"key":"ref=50","first-page":"1074","volume":"19","author":"Marques K.M.R.","year":"2019","unstructured":"Marques K.M.R.; do Desterro M.R.; de Arruda S.M.; de Ara\u00fajo Neto L.N.; de Lima M.d.C.A.; de Almeida S.M.V.; da Silva E.C.D.; de Aquino T.M.; da Silva-J\u00fanior E.F.; de Ara\u00fajo-J\u00fanior J.X.; Silva M.d.M.; Dantas M.D.d.A.; Santos J.C.C.; Figueiredo I.M.; Bazin M-A.; Marchand P.; da Silva T.G.; Mendon\u00e7a Junior; 5-Nitro-thiophene-thiosemicarbazone derivatives present antitumor activity mediated by apoptosis and dna intercalation. Curr Top Med Chem 2019,19(13),1074-1091","journal-title":"Curr Top Med Chem"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2174\/1568026619666190520083655","volume":"19","author":"Azimi F.","year":"2019","unstructured":"Azimi F.; Ghasemi J.B.; Saghaei L.; Hassanzadeh F.; Mahdavi M.; Sadeghi-aliabadi H.; Scotti M.T.; Scotti L.; Identification of essential 2D and 3D chemical features for discovery of the novel tubulin polymerization inhibitors. Curr Top Med Chem 2019,19(13),1092-1120","journal-title":"Curr Top Med Chem"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2174\/1568026619666190618143552","volume":"19","author":"Tugcu G.","year":"2019","unstructured":"Tugcu G.; Sipahi H.; Ayd\u0131n A.; Application of a validated QSTR model for repurposing cox-2 inhibitor coumarin derivatives as potential antitumor agents. Curr Top Med Chem 2019,19(13),1121-1128","journal-title":"Curr Top Med Chem"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2174\/1568026619666190521084941","volume":"19","author":"Sharda S.","year":"2019","unstructured":"Sharda S.; Khandelwal R.; Adhikary R.; Sharma D.; Majhi M.; Hussain T.; Nayarisseri A.; Singh S.K.; A computer-aided drug designing for pharmacological inhibition of mutant alk for the treatment of non-small cell lung cancer. Curr Top Med Chem 2019,19(13),1129-1144","journal-title":"Curr Top Med Chem"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/1568026619666190523080136","volume":"19","author":"Kartsev V.","year":"2019","unstructured":"Kartsev V.; Geronikaki A.; Petrou A.; Lichitsky B.; Sirakanyan S.; Kostic M.; Smiljkovic M.; Sokovi\u0107 M.; Griseofulvin derivatives: Synthesis, molecular docking and biological evaluation. Curr Top Med Chem 2019,19(13),1145-1161","journal-title":"Curr Top Med Chem"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2174\/1568026619666190618142432","volume":"19","author":"Kanakaveti V.","year":"2019","unstructured":"Kanakaveti V.; Sakthivel R.; Rayala S.K.; Gromiha M.M.; Forging new scaffolds from old: combining scaffold hopping and hierarchical virtual screening for identifying novel bcl-2 inhibitors. Curr Top Med Chem 2019,19(13),1162-1172","journal-title":"Curr Top Med Chem"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1568026619666190617155326","volume":"19","author":"Ali M.A.","year":"2019","unstructured":"Ali M.A.; Vuree S.; Goud H.; Hussain T.; Nayarisseri A.; Singh S.K.; Identification of high-affinity small molecules targeting gamma secretase for the treatment of alzheimer\u2019s disease. Curr Top Med Chem 2019,19(13),1173-1187","journal-title":"Curr Top Med Chem"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/174468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T01:23:39Z","timestamp":1574472219000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/174468\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":56,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,8,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/156802661913190827102426","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}